Skip to main content

Advertisement

SpringerLink
Log in

Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer’s disease

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Blennow K, Wallin A, Gottfries CG, et al. (1992) Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer’s disease. Neurobiol Aging 13:107–113

    Article  CAS  PubMed  Google Scholar 

  2. Hu XS, Okamura N, Arai H, et al. (2000) 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology 55:1575–1576

    Article  CAS  PubMed  Google Scholar 

  3. Kanemaru K, Kameda N, Yamanouchi H (2000) Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies. Neurology 54:1875–1876

    Article  CAS  PubMed  Google Scholar 

  4. McKeith IG, Galasko D, Kosaka K, et al. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124

    Article  CAS  PubMed  Google Scholar 

  5. McKhann G, Drachman D, Folstein M, et al. (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services task force on Alzheimer’s disease. Neurology 34: 939–944

    Article  CAS  PubMed  Google Scholar 

  6. Walker Z, Costa DC, Ince P, McKeith IG, Katona CLE (1999) In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies. Lancet 354:646–647

    Article  CAS  PubMed  Google Scholar 

  7. Weiner MF, Risser RC, Cullum CM, et al. (1996) Alzheimer’s disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry 153:1269–1273

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan

    Kazutomi Kanemaru MD & Hiroshi Yamanouchi

Authors
  1. Kazutomi Kanemaru MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Yamanouchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazutomi Kanemaru MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanemaru, K., Yamanouchi, H. Assessment of CSF homovanillic acid levels distinguishes dementia with Lewy bodies from Alzheimer’s disease. J Neurol 249, 1125–1126 (2002). https://doi.org/10.1007/s00415-002-0753-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-002-0753-x

Keywords

Search

Navigation